Hetlioz Pill

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Tasimelteon (Hetlioz®) is a dual melatonin receptor agonist indicated for the treatment of Non-24-Hour Sleep-Wake Disorder (Non… Expand
  • table 1
Is this relevant?
Review
2015
Review
2015
Tasimelteon (Hetlioz®), a melatonin receptor agonist, is the first, and, at the time of the publication, the only drug to be… Expand
Is this relevant?